Add
MRK to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| MRK > SEC Filings for MRK > Form 8-K on 1-Jul-2009 | All Recent SEC Filings |
1-Jul-2009
Other Events, Financial Statements and Exhibits
On June 25, 2009, Merck & Co., Inc. (the "Company") closed an underwritten public offering of $1,250,000,000 aggregate principal amount of 1.875% Notes due 2011 (the "2011 Notes"), $1,000,000,000 aggregate principal amount of 4.000% Notes due 2015 (the "2015 Notes"), $1,250,000,000 aggregate principal amount of 5.000% Notes due 2019 (the "2019 Notes") and $750,000,000 aggregate principal amount of 5.850% Notes due 2039 (the "2039 Notes" and, together with the 2011 Notes, the 2015 Notes and the 2019 Notes, the "Notes") under the Company's Registration Statement on Form S-3 (Registration No. 333-160134).
Copies of the officers' certificate for each series of the Notes (including forms of each of the respective Notes attached thereto) pursuant to Section 301 of the indenture governing the Notes are attached hereto as Exhibits 4.1, 4.2, 4.3 and 4.4 and are incorporated herein by reference.
(d) Exhibits.
4.1 1.875% Notes due 2011 Officers' Certificate of the Company dated June 25, 2009, including form of the 2011 Notes.
4.2 4.000% Notes due 2015 Officers' Certificate of the Company dated June 25, 2009, including form of the 2015 Notes.
4.3 5.000% Notes due 2019 Officers' Certificate of the Company dated June 25, 2009, including form of the 2019 Notes.
4.4 5.850% Notes due 2039 Officers' Certificate of the Company dated June 25, 2009, including form of the 2039 Notes.
|
|